Coronavirus- 2019-nCoV - COVID-19
The Coronavirus (named 2019-nCoV) emerged in Wuhan, China in December 2019. WHO declared a global health emergency on 30 January 2020,and a number of blood and tissue donor guidelines have been issued - largely based on previous guidelines for SARS-CoV and MERS-CoV. Like SARS and MERS, 2019-nCoV displayed high mortality but low infectivity in the early weeks, with limited person-to-person transmission. However, the epidemic quickly changed to display lower mortality but higher infectivity with increasing evidence of sustained person-to-person transmission.
Various public health measures taken at local or national level are likely to aid and/or complicate donor assessment, while the rapid evolution of the epidemic demands a precautionary yet flexible approach to suitability guidelines.
Read more here:
Continuity of Care during the COVID-19 crisis
WMDA wants to support continuity of care at this challencing time. Join us this week for a daily webinar to connect with you, our members, to give you the opportunity to connect with us and with each other as a community. Share your concerns, solutions, strategies and your ideas how to cope with this new reality we're faced with. Click on the title below to join live at the given date and time.
Irina Evseeva of Anthony Nolan will explain to you what support you will receive from the cord blood selection service and how it works.
Our medical team will explain the donor suitability criteria and respond to the questions you may have for donor care.
Weblinks to the daily webinars
Unfortunately, the first webinar, presented by WMDA's President, Jeff Szer, and Chair of the Donor Medical Suitability Committee, Hung Yang, wasn't recorded.
WMDA International Emergency Task Force – Transport challenges
Gabi Rall of DKMS gives you an update on the work that has been done by the WMDA International Emergency Task Force and explore with you how they can support you more in the next weeks. Find Gabi's presentation here.
|Wmda button red|
In need of help? Question or suggestion?